AstraZeneca plc vs Nu Holdings Ltd — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Nu Holdings Ltd trades at $13.68 (market cap $65.94B). The key difference: AstraZeneca plc is far larger — about 3.8× Nu Holdings Ltd's market cap, and AstraZeneca plc pays a 2.01% dividend while Nu Holdings Ltd pays none. Which is the better fit depends on your goals.
| AZN | NU | |
|---|---|---|
Market Cap | $248.14B | $65.94B |
Sector | Health | Financials |
52-Week High | $209.48 | $18.76 |
52-Week Low | $147.06 | $11.60 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →